Design
Review
Authors
Loading...
May guide targeted antithrombotic development; leaves open clinical validation of receptor-specific agents in trials.
Key points are not available for this paper at this time.
Oury et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: